Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Douglas Berthiaume and More

Premium

Waters said this week that Douglas Berthiaume plans to retire from his position as CEO of the company sometime in the next two years.

The company's board of directors has appointed a succession planning committee to lead the selection of a successor, and it plans to hire an executive search firm. Waters said it plans to consider candidates who are already with the company and external candidates as well.

Berthiaume was appointed president and CEO of Waters in 1994, when the business was split from Millipore, and he took on the role of chairman in 1996. During his tenure, Waters said, the company has seen a 500 percent increase in revenues and a 25-fold increase in its share price since its IPO in 1995.


Biotheranostics has added three new members to its senior management team, including Gail Sloan as CFO, Macey Johnson as VP of managed care and reimbursement, and Matt Sargent as Breast Cancer Index commercialization leader.

Sloan previously was assistant controller at Affymax Research Institute, where she helped lead the spinoff of Affymetrix, and she was CFO and VP of finance at La Jolla Pharmaceutical. Johnson formerly worked at Genomic Health, where he developed managed care messaging and strategy for molecular assays, and he worked at Genentech, where he helped launch Avastin, Herceptin, and Tarceva.

Sargent recently was VP of oncology sales for Caris Life Sciences, where he built and trained the oncology sales team, and he has held senior sales and marketing positions at Exiqon Diagnostics and MedTrust Online.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.